Global Renal Disease Market Research Report 2023

Report ID: 1988062 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Renal Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Acute Kidney Problems
        1.2.3 Chronic Kidney Diseases
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Renal Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Research Center
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Renal Disease Market Perspective (2017-2028)
    2.2 Renal Disease Growth Trends by Region
        2.2.1 Renal Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Renal Disease Historic Market Size by Region (2017-2022)
        2.2.3 Renal Disease Forecasted Market Size by Region (2023-2028)
    2.3 Renal Disease Market Dynamics
        2.3.1 Renal Disease Industry Trends
        2.3.2 Renal Disease Market Drivers
        2.3.3 Renal Disease Market Challenges
        2.3.4 Renal Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Renal Disease Players by Revenue
        3.1.1 Global Top Renal Disease Players by Revenue (2017-2022)
        3.1.2 Global Renal Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Renal Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Renal Disease Revenue
    3.4 Global Renal Disease Market Concentration Ratio
        3.4.1 Global Renal Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Renal Disease Revenue in 2021
    3.5 Renal Disease Key Players Head office and Area Served
    3.6 Key Players Renal Disease Product Solution and Service
    3.7 Date of Enter into Renal Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Disease Breakdown Data by Type
    4.1 Global Renal Disease Historic Market Size by Type (2017-2022)
    4.2 Global Renal Disease Forecasted Market Size by Type (2023-2028)
5 Renal Disease Breakdown Data by Application
    5.1 Global Renal Disease Historic Market Size by Application (2017-2022)
    5.2 Global Renal Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Renal Disease Market Size (2017-2028)
    6.2 North America Renal Disease Market Size by Country (2017-2022)
    6.3 North America Renal Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Renal Disease Market Size (2017-2028)
    7.2 Europe Renal Disease Market Size by Country (2017-2022)
    7.3 Europe Renal Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Renal Disease Market Size (2017-2028)
    8.2 Asia-Pacific Renal Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Renal Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Renal Disease Market Size (2017-2028)
    9.2 Latin America Renal Disease Market Size by Country (2017-2022)
    9.3 Latin America Renal Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Renal Disease Market Size (2017-2028)
    10.2 Middle East & Africa Renal Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Renal Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott (US)
        11.1.1 Abbott (US) Company Detail
        11.1.2 Abbott (US) Business Overview
        11.1.3 Abbott (US) Renal Disease Introduction
        11.1.4 Abbott (US) Revenue in Renal Disease Business (2017-2022)
        11.1.5 Abbott (US) Recent Development
    11.2 Amgen Inc. (US)
        11.2.1 Amgen Inc. (US) Company Detail
        11.2.2 Amgen Inc. (US) Business Overview
        11.2.3 Amgen Inc. (US) Renal Disease Introduction
        11.2.4 Amgen Inc. (US) Revenue in Renal Disease Business (2017-2022)
        11.2.5 Amgen Inc. (US) Recent Development
    11.3 Baxter (US)
        11.3.1 Baxter (US) Company Detail
        11.3.2 Baxter (US) Business Overview
        11.3.3 Baxter (US) Renal Disease Introduction
        11.3.4 Baxter (US) Revenue in Renal Disease Business (2017-2022)
        11.3.5 Baxter (US) Recent Development
    11.4 Bristol-Myers Squibb Company (US)
        11.4.1 Bristol-Myers Squibb Company (US) Company Detail
        11.4.2 Bristol-Myers Squibb Company (US) Business Overview
        11.4.3 Bristol-Myers Squibb Company (US) Renal Disease Introduction
        11.4.4 Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Company (US) Recent Development
    11.5 Keryx Biopharmaceuticals(US)
        11.5.1 Keryx Biopharmaceuticals(US) Company Detail
        11.5.2 Keryx Biopharmaceuticals(US) Business Overview
        11.5.3 Keryx Biopharmaceuticals(US) Renal Disease Introduction
        11.5.4 Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2017-2022)
        11.5.5 Keryx Biopharmaceuticals(US) Recent Development
    11.6 NephroGenex(US)
        11.6.1 NephroGenex(US) Company Detail
        11.6.2 NephroGenex(US) Business Overview
        11.6.3 NephroGenex(US) Renal Disease Introduction
        11.6.4 NephroGenex(US) Revenue in Renal Disease Business (2017-2022)
        11.6.5 NephroGenex(US) Recent Development
    11.7 Novartis AG (Switzerland)
        11.7.1 Novartis AG (Switzerland) Company Detail
        11.7.2 Novartis AG (Switzerland) Business Overview
        11.7.3 Novartis AG (Switzerland) Renal Disease Introduction
        11.7.4 Novartis AG (Switzerland) Revenue in Renal Disease Business (2017-2022)
        11.7.5 Novartis AG (Switzerland) Recent Development
    11.8 Pfizer Inc.(US)
        11.8.1 Pfizer Inc.(US) Company Detail
        11.8.2 Pfizer Inc.(US) Business Overview
        11.8.3 Pfizer Inc.(US) Renal Disease Introduction
        11.8.4 Pfizer Inc.(US) Revenue in Renal Disease Business (2017-2022)
        11.8.5 Pfizer Inc.(US) Recent Development
    11.9 Sanofi (France)
        11.9.1 Sanofi (France) Company Detail
        11.9.2 Sanofi (France) Business Overview
        11.9.3 Sanofi (France) Renal Disease Introduction
        11.9.4 Sanofi (France) Revenue in Renal Disease Business (2017-2022)
        11.9.5 Sanofi (France) Recent Development
    11.10 Shire Pharmaceuticals Limited (Republic of Ireland)
        11.10.1 Shire Pharmaceuticals Limited (Republic of Ireland) Company Detail
        11.10.2 Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
        11.10.3 Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Introduction
        11.10.4 Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2017-2022)
        11.10.5 Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Renal Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Acute Kidney Problems
    Table 3. Key Players of Chronic Kidney Diseases
    Table 4. Key Players of Others
    Table 5. Global Renal Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Renal Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Renal Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Renal Disease Market Share by Region (2017-2022)
    Table 9. Global Renal Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Renal Disease Market Share by Region (2023-2028)
    Table 11. Renal Disease Market Trends
    Table 12. Renal Disease Market Drivers
    Table 13. Renal Disease Market Challenges
    Table 14. Renal Disease Market Restraints
    Table 15. Global Renal Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Renal Disease Market Share by Players (2017-2022)
    Table 17. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Disease as of 2021)
    Table 18. Ranking of Global Top Renal Disease Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Renal Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Renal Disease Product Solution and Service
    Table 22. Date of Enter into Renal Disease Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Renal Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Renal Disease Revenue Market Share by Type (2017-2022)
    Table 26. Global Renal Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Renal Disease Revenue Market Share by Type (2023-2028)
    Table 28. Global Renal Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Renal Disease Revenue Market Share by Application (2017-2022)
    Table 30. Global Renal Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Renal Disease Revenue Market Share by Application (2023-2028)
    Table 32. North America Renal Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Renal Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Renal Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Renal Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Renal Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Renal Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Renal Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Renal Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Renal Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Renal Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Abbott (US) Company Detail
    Table 43. Abbott (US) Business Overview
    Table 44. Abbott (US) Renal Disease Product
    Table 45. Abbott (US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 46. Abbott (US) Recent Development
    Table 47. Amgen Inc. (US) Company Detail
    Table 48. Amgen Inc. (US) Business Overview
    Table 49. Amgen Inc. (US) Renal Disease Product
    Table 50. Amgen Inc. (US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 51. Amgen Inc. (US) Recent Development
    Table 52. Baxter (US) Company Detail
    Table 53. Baxter (US) Business Overview
    Table 54. Baxter (US) Renal Disease Product
    Table 55. Baxter (US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 56. Baxter (US) Recent Development
    Table 57. Bristol-Myers Squibb Company (US) Company Detail
    Table 58. Bristol-Myers Squibb Company (US) Business Overview
    Table 59. Bristol-Myers Squibb Company (US) Renal Disease Product
    Table 60. Bristol-Myers Squibb Company (US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 61. Bristol-Myers Squibb Company (US) Recent Development
    Table 62. Keryx Biopharmaceuticals(US) Company Detail
    Table 63. Keryx Biopharmaceuticals(US) Business Overview
    Table 64. Keryx Biopharmaceuticals(US) Renal Disease Product
    Table 65. Keryx Biopharmaceuticals(US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 66. Keryx Biopharmaceuticals(US) Recent Development
    Table 67. NephroGenex(US) Company Detail
    Table 68. NephroGenex(US) Business Overview
    Table 69. NephroGenex(US) Renal Disease Product
    Table 70. NephroGenex(US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 71. NephroGenex(US) Recent Development
    Table 72. Novartis AG (Switzerland) Company Detail
    Table 73. Novartis AG (Switzerland) Business Overview
    Table 74. Novartis AG (Switzerland) Renal Disease Product
    Table 75. Novartis AG (Switzerland) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 76. Novartis AG (Switzerland) Recent Development
    Table 77. Pfizer Inc.(US) Company Detail
    Table 78. Pfizer Inc.(US) Business Overview
    Table 79. Pfizer Inc.(US) Renal Disease Product
    Table 80. Pfizer Inc.(US) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 81. Pfizer Inc.(US) Recent Development
    Table 82. Sanofi (France) Company Detail
    Table 83. Sanofi (France) Business Overview
    Table 84. Sanofi (France) Renal Disease Product
    Table 85. Sanofi (France) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 86. Sanofi (France) Recent Development
    Table 87. Shire Pharmaceuticals Limited (Republic of Ireland) Company Detail
    Table 88. Shire Pharmaceuticals Limited (Republic of Ireland) Business Overview
    Table 89. Shire Pharmaceuticals Limited (Republic of Ireland) Renal Disease Product
    Table 90. Shire Pharmaceuticals Limited (Republic of Ireland) Revenue in Renal Disease Business (2017-2022) & (US$ Million)
    Table 91. Shire Pharmaceuticals Limited (Republic of Ireland) Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Renal Disease Market Share by Type: 2021 VS 2028
    Figure 2. Acute Kidney Problems Features
    Figure 3. Chronic Kidney Diseases Features
    Figure 4. Others Features
    Figure 5. Global Renal Disease Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Research Center Case Studies
    Figure 9. Others Case Studies
    Figure 10. Renal Disease Report Years Considered
    Figure 11. Global Renal Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Renal Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Renal Disease Market Share by Region: 2021 VS 2028
    Figure 14. Global Renal Disease Market Share by Players in 2021
    Figure 15. Global Top Renal Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Disease as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Renal Disease Revenue in 2021
    Figure 17. North America Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Renal Disease Market Share by Country (2017-2028)
    Figure 19. United States Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Renal Disease Market Share by Country (2017-2028)
    Figure 23. Germany Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Renal Disease Market Share by Region (2017-2028)
    Figure 31. China Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Renal Disease Market Share by Country (2017-2028)
    Figure 39. Mexico Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Renal Disease Market Share by Country (2017-2028)
    Figure 43. Turkey Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Renal Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Abbott (US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 46. Amgen Inc. (US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 47. Baxter (US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 48. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 49. Keryx Biopharmaceuticals(US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 50. NephroGenex(US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 51. Novartis AG (Switzerland) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 52. Pfizer Inc.(US) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 53. Sanofi (France) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 54. Shire Pharmaceuticals Limited (Republic of Ireland) Revenue Growth Rate in Renal Disease Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott (US)
Amgen Inc. (US)
Baxter (US)
Bristol-Myers Squibb Company (US)
Keryx Biopharmaceuticals(US)
NephroGenex(US)
Novartis AG (Switzerland)
Pfizer Inc.(US)
Sanofi (France)
Shire Pharmaceuticals Limited (Republic of Ireland)
Frequently Asked Questions
Renal Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Renal Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Renal Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rendered Products

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Respiratory Inhalers

Respiratory Inhalers market is segmented by players, region (country), by Type and by Application ... Read More

Retinal Detachment

Retinal Detachment market is segmented by players, region (country), by Type and by Application.  ... Read More